Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability

J Biol Chem. 2020 Apr 3;295(14):4647-4660. doi: 10.1074/jbc.RA119.011273. Epub 2020 Feb 21.

Abstract

Vascular endothelial growth factor (VEGF) contributes to blood-retinal barrier (BRB) dysfunction in several blinding eye diseases, including diabetic retinopathy. Signaling via the secreted protein norrin through the frizzled class receptor 4 (FZD4)/LDL receptor-related protein 5-6 (LRP5-6)/tetraspanin 12 (TSPAN12) receptor complex is required for developmental vascularization and BRB formation. Here, we tested the hypothesis that norrin restores BRB properties after VEGF-induced vascular permeability in diabetic rats or in animals intravitreally injected with cytokines. Intravitreal co-injection of norrin with VEGF completely ablated VEGF-induced BRB permeability to Evans Blue-albumin. Likewise, 5-month diabetic rats exhibited increased permeability of FITC-albumin, and a single norrin injection restored BRB properties. These results were corroborated in vitro, where co-stimulation of norrin with VEGF or stimulation of norrin after VEGF exposure restored barrier properties, indicated by electrical resistance or 70-kDa RITC-dextran permeability in primary endothelial cell culture. Interestingly, VEGF promoted norrin signaling by increasing the FZD4 co-receptor TSPAN12 at cell membranes in an MAPK/ERK kinase (MEK)/ERK-dependent manner. Norrin signaling through β-catenin was required for BRB restoration, but glycogen synthase kinase 3 α/β (GSK-3α/β) inhibition did not restore BRB properties. Moreover, levels of the tight junction protein claudin-5 were increased with norrin and VEGF or with VEGF alone, but both norrin and VEGF were required for enriched claudin-5 localization at the tight junction. These results suggest that VEGF simultaneously induces vascular permeability and promotes responsiveness to norrin. Norrin, in turn, restores tight junction complex organization and BRB properties in a β-catenin-dependent manner.

Keywords: Wnt signaling; blood-retinal barrier; cell signaling; diabetic retinopathy; endothelium; norrin; permeability; retina; tetraspanin; tetraspanin 12 (TSPAN12); tight junction; vascular endothelial growth factor (VEGF).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood-Retinal Barrier / drug effects
  • Blood-Retinal Barrier / metabolism*
  • Capillary Permeability / drug effects*
  • Cattle
  • Claudin-5 / metabolism
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / pathology
  • Eye Proteins / pharmacology*
  • Male
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Rats
  • Rats, Long-Evans
  • Retina / metabolism
  • Retinal Vessels / cytology
  • Retinal Vessels / metabolism
  • Signal Transduction / drug effects
  • Tetraspanins / genetics
  • Tetraspanins / metabolism
  • Up-Regulation / drug effects
  • Vascular Endothelial Growth Factor A / pharmacology*
  • beta Catenin / antagonists & inhibitors
  • beta Catenin / metabolism

Substances

  • Claudin-5
  • Eye Proteins
  • Tetraspanins
  • Vascular Endothelial Growth Factor A
  • beta Catenin
  • Mitogen-Activated Protein Kinase Kinases